Key Insights

Highlights

Success Rate

79% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.4%

6 terminated out of 64 trials

Success Rate

78.6%

-8.0% vs benchmark

Late-Stage Pipeline

11%

7 trials in Phase 3/4

Results Transparency

23%

5 of 22 completed with results

Key Signals

5 with results79% success

Data Visualizations

Phase Distribution

33Total
Not Applicable (8)
Early P 1 (1)
P 1 (5)
P 2 (12)
P 3 (2)
P 4 (5)

Trial Status

Completed22
Recruiting15
Unknown10
Not Yet Recruiting7
Terminated6
Active Not Recruiting3

Trial Success Rate

78.6%

Benchmark: 86.6%

Based on 22 completed trials

Clinical Trials (64)

Showing 20 of 20 trials
NCT07827235Not Yet Recruiting

Thyroid Disorders in Pediatric Autoimmune Hepatitis

NCT04902807Completed

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

NCT07784881CompletedPrimary

Deciphering the Self-antigen Specific T Cell Signature of Autoimmune Liver Diseases

NCT05750498RecruitingPrimary

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

NCT03175471Recruiting

MRI Based Biomarkers in Pediatric Autoimmune Liver Disease

NCT03178630Recruiting

MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease

NCT07598825Phase 3Not Yet RecruitingPrimary

A Trial of Inebilizumab in Participants With Autoimmune Hepatitis

NCT06061341Terminated

TruGraf Liver Gene Expression Serial Test

NCT05810480RecruitingPrimary

PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive Immunoglobulin G

NCT07644936Not Yet RecruitingPrimary

Molecular Characterization of Autoimmune Hepatitis: A Lipidomic Approach

NCT05532345Completed

Discrimination of DILI and AIH by Artificial Intelligence

NCT07118657Not ApplicableRecruitingPrimary

Host-Diet-Gut Interaction Post Vegan Diet in Pediatric Autoimmune Hepatitis.

NCT06250309Not ApplicableRecruitingPrimary

Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients

NCT06381453Phase 2RecruitingPrimary

Belimumab in Autoimmune Hepatitis

NCT06519162RecruitingPrimary

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

NCT03217422Phase 2CompletedPrimary

ADCC Mediated B-Cell dEpletion and BAFF-R Blockade

NCT07378202Active Not RecruitingPrimary

Machine Learning for Prediction of Therapy Response in Autoimmune Hepatitis

NCT05569759Phase 2CompletedPrimary

A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)

NCT05740358Active Not Recruiting

Liver Cirrhosis Network Cohort Study

NCT03743272Completed

Repeatability and Reproducibility of Multiparametric MRI

Scroll to load more

Research Network

Activity Timeline